Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Horizon Discvry LSE:HZD London Ordinary Share GB00BK8FL363 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -2.50p -1.39% 177.50p 5,095 10:04:14
Bid Price Offer Price High Price Low Price Open Price
175.50p 180.00p 177.50p 177.50p 177.50p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 36.51 -14.34 -8.40 266.8

Horizon Discvry (HZD) Latest News

More Horizon Discvry News
Horizon Discvry Takeover Rumours

Horizon Discvry (HZD) Share Charts

1 Year Horizon Discvry Chart

1 Year Horizon Discvry Chart

1 Month Horizon Discvry Chart

1 Month Horizon Discvry Chart

Intraday Horizon Discvry Chart

Intraday Horizon Discvry Chart

Horizon Discvry (HZD) Discussions and Chat

Horizon Discvry Forums and Chat

Date Time Title Posts
12/11/201810:08Horizon Discovery Ltd - Genomic translation 1,052
04/10/201811:17Horizon Discovery (HZD) One to Watch -
23/7/201414:43Alan Green says to BUY and HOLD in Horizon-

Add a New Thread

Horizon Discvry (HZD) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
08:55:14177.502,5114,457.03AT
08:55:08177.502,2273,952.93O
08:03:57176.33357629.50O
2018-12-11 17:07:32180.01151271.81O
2018-12-11 16:51:40179.94486874.53O
View all Horizon Discvry trades in real-time

Horizon Discvry (HZD) Top Chat Posts

DateSubject
12/12/2018
08:20
Horizon Discvry Daily Update: Horizon Discvry is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker HZD. The last closing price for Horizon Discvry was 180p.
Horizon Discvry has a 4 week average price of 167.50p and a 12 week average price of 167.50p.
The 1 year high share price is 252p while the 1 year low share price is currently 128p.
There are currently 150,333,908 shares in issue and the average daily traded volume is 22,502 shares. The market capitalisation of Horizon Discvry is £266,842,686.70.
01/11/2018
12:04
kestelmill: Not convinced that a technical webinar is going to lead to share price movement!
01/11/2018
11:24
jurgenklopp: This has been very quiet in the last few days. However the CRISPR webinar on the 7th November might just kick start some upward momentum in the share price.
15/10/2018
09:42
bouleversee: So the share price takes a steep vertical dive! Explain, please.
03/8/2018
10:35
jurgenklopp: Short term lowering of positive EBITDA for FY 2018 did not detract from the very promising future prospects. Indeed, without that decrease in guidance for this year, I suspect the shares would have been north of 200p today on the rest of the update. So much so that I, too, couldn't resist a small top up at a tad under 179p. When this does attract attention and the subsequent momentum the share price ought to do very well.
21/5/2018
11:27
bouleversee: I see from an article in Sunday Times Business (I'm afraid I haven't yet got round to studying the Annual Report) that "Darren Disley was handed a year-long payout after his shock departure: £321,507 in lieu of base salary, benefits and accrued annual leave for l2 months. He also has options over shares worth almost £2m at today's share price. Disley was not required to go on gardening leave." The article also says that "Horizon said it had also "refocused" the business to concentrate on its core products and reduce the level of investment in its own therapies. The change of direction will suit the new chief executive, Terry Pizzie, who comes from a commercial background." I'm not clear as to what that will mean precisely and whether and when it is likely to start making any sort of return to shareholders rather than losing their capital. Will we ever know the real reason Disley left?
11/5/2018
11:28
mamcw: Very odd share price behaviour - another bid coming?
03/5/2018
09:15
kestelmill: Comments from the man himself: "Quite right too given the value of the business was underpinned by existing investors, GE Healthcare and new US investors only in September 2017 at 205p (£305M) in the £65M acquisition of Dharmacon and £40M secondary placement. Given this deal was reported in the financial press as: doubling the top line of Horizon whilst adding significant profit; the consensus of six analysts is north of £2.50; and the share price spent most of the time in H2,17 in the £2.40 (£358M) to £2.70 (£402M) range then in my personal opinion I think the board has a very strong case to reject this offer." "As at today’s closing price of 190p Horizon is trading on a forward 12 month consensus revenue basis at 4.7X. AbCam is trading at >10X. Organic growth for AbCam is forecast by analysts at c10% with Horizon forecast to grow at c15%. Both products businesses are forecast to have similar gross margins on forward 12 month basis. Even if you take into account a much deserved premium for the historical results performance consistency of AbCam you have to consider this is also the year Horizon is forecast by analysts to generate cash so on a revenue multiple comparison versus peers the analyst consensus of 260p a share (£388M) or 6.5X consensus revenue seems sound. Even at that level the deal would be highly accretive to AbCam shareholders. Horizons shareholders need to hold firm. If they want to sell in due course there are much better deals than this to be had. I should state that this is all said in my personal capacity as a shareholder and all opinions based on public domain information."
21/2/2018
16:15
mamcw: On further enquiries, it does seem that this was a boardroom bust-up. What's intriguing is that normally when you lose a CEO of 11 years' standing who is the driving force behind the company, the share price tanks. Instead, it has rallied today. Makes you wonder what is really going on - a potential bidder? Numis apparently being very economical with any information. DYOR
05/2/2018
20:26
gnnmartin: I've just looked again at the interim presentation and the pre close update, and noticed that we seem to have gone from "FY17 guidance ... • Group EBITDA approximately break-even before exceptionals and discontinued operations" in the half year presentation to "The Group expects that reported EBITDA before exceptional items and discontinued operations for the full year will be in line with the analyst consensus forecast loss of (£1.7) million" in the pre close RNS. I guess that with the weakness in the markets generally explains the share price fall.
20/7/2017
16:30
xippy: They have clearly got the placing away with city institutions. These boys don't generally trade for a quick buck. If we've got serious ii interest then current rise in share price speaks volumes of where they see the company going. A large placing and the share price rises by 25% is great news. Lots of ii's have confidence in this. I'm locking my shares away and will look at them periodically. Personally I expect some further gains and eventually good dividends. Imho, Dyor
Horizon Discvry share price data is direct from the London Stock Exchange
Your Recent History
LSE
HZD
Horizon Di..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181212 10:33:59